Taneva Irina, Grumann Dorothee, Schmidt Dietmar, Taneva Elina, von Arnim Ulrike, Ansorge Thomas, Wex Thomas
Department of Molecular Genetics, Medical Laboratory for Clinical Chemistry, Microbiology, Infectious Diseases and Genetics "Prof. Schenk/Dr. Ansorge and Colleagues", Schwiesaustr. 11, 39124, Magdeburg, Germany.
Medical Office Internal Medicine and Gastroenterology, Olvenstedter Str. 11, 39108, Magdeburg, Germany.
BMC Gastroenterol. 2022 Apr 6;22(1):167. doi: 10.1186/s12876-022-02244-7.
While role of ALDOB-related gene variants for hereditary fructose intolerance is well established, contribution of gene variants for acquired fructose malabsorption (e.g. SLC2A5, GLUT5) is not well understood.
Patients referred to fructose breath test were further selected to identify those having acquired fructose malabsorption. Molecular analysis of genomic DNA included (I) exclusion of 3 main ALDOB gene variants causing hereditary fructose intolerance and (II) sequencing analysis of SLC2A5 gene comprising complete coding region, at least 20 bp of adjacent intronic regions and 700 bp of proximal promoter.
Among 494 patients, 35 individuals with acquired fructose malabsorption were identified based on pathological fructose-breath test and normal lactose-breath test. Thirty four of them (97%) had negative tissue anti-transglutaminase and/or deamidated gliadin antibodies in their medical records. Molecular analysis of SLC2A5 gene of all 35 subjects identified 5 frequent and 5 singular gene variants mostly in noncoding regions (promoter and intron). Allele frequencies of gene variants were similar to those reported in public databases strongly implying that none of them was associated with acquired fructose malabsorption.
Gene variants of coding exons, adjacent intronic regions and proximal promoter region of SLC2A5 gene are unlikely to contribute to genetic predisposition of acquired fructose malabsorption.
虽然与醛缩酶B(ALDOB)相关的基因变异在遗传性果糖不耐受中的作用已得到充分证实,但基因变异对获得性果糖吸收不良(如溶质载体家族2成员5基因(SLC2A5)、葡萄糖转运蛋白5(GLUT5))的贡献尚不清楚。
对接受果糖呼气试验的患者进一步筛选,以确定那些患有获得性果糖吸收不良的患者。基因组DNA的分子分析包括:(I)排除导致遗传性果糖不耐受的3种主要ALDOB基因变异;(II)对包含完整编码区、至少20bp相邻内含子区域和700bp近端启动子的SLC2A5基因进行测序分析。
在494例患者中,根据病理性果糖呼气试验和正常乳糖呼气试验,确定了35例获得性果糖吸收不良患者。其中34例(97%)的病历中组织型抗转谷氨酰胺酶和/或去酰胺化麦醇溶蛋白抗体呈阴性。对所有35名受试者的SLC2A5基因进行分子分析,发现5种常见和5种罕见基因变异,大多位于非编码区(启动子和内含子)。基因变异的等位基因频率与公共数据库中报告的频率相似,强烈表明它们均与获得性果糖吸收不良无关。
SLC2A5基因编码外显子、相邻内含子区域和近端启动子区域的基因变异不太可能导致获得性果糖吸收不良的遗传易感性。